enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Ivermectin during the COVID-19 pandemic - Wikipedia

    en.wikipedia.org/wiki/Ivermectin_during_the...

    Ball-and-stick model of Ivermectin. Ivermectin is an antiparasitic drug that is well established for use in animals and people. [1] The World Health Organization (WHO), [2] the European Medicines Agency (EMA), [3] the United States Food and Drug Administration (FDA), [4] and the Infectious Diseases Society of America (IDSA) [5] all advise against using ivermectin in an attempt to treat or ...

  3. Treatment and management of COVID-19 - Wikipedia

    en.wikipedia.org/wiki/Treatment_and_management...

    This registry based, multi-center, multi-country data provide provisional support for the use of ECMO for COVID-19 associated acute hypoxemic respiratory failure. Given that this is a complex technology that can be resource intense, guidelines exist for the use of ECMO during the COVID-19 pandemic. [85] [86] [87]

  4. Casirivimab/imdevimab - Wikipedia

    en.wikipedia.org/wiki/Casirivimab/imdevimab

    In July 2021, the US FDA revised the emergency use authorization (EUA) for REGEN‑COV (casirivimab and imdevimab, administered together) authorizing REGEN‑COV for emergency use as post-exposure prophylaxis (prevention) for COVID‑19 in people aged twelve years of age and older weighing at least 40 kilograms (88 lb) who are at high risk for ...

  5. FDA grants emergency use authorization for COVID-19 drug - AOL

    www.aol.com/fda-grants-emergency-authorization...

    Pemgarda, made by Invivyd, is an infusion drug made for those who are immunocompromised to help support the immune system in preventing COVID-19 infection. The Food and Drug Administration granted ...

  6. Molnupiravir - Wikipedia

    en.wikipedia.org/wiki/Molnupiravir

    The primary data supporting the US Food and Drug Administration (FDA) emergency use authorization for molnupiravir are from MOVe-OUT, a randomized, double-blind, placebo-controlled clinical trial studying molnupiravir for the treatment of non-hospitalized participants with mild to moderate COVID‑19 at high risk for progression to severe COVID ...

  7. Convidecia - Wikipedia

    en.wikipedia.org/wiki/Convidecia

    In August, China's National Intellectual Property Administration issued the country's first COVID-19 vaccine patent to CanSino. [34] On 16 May 2020, Canadian Prime Minister Justin Trudeau announced Health Canada had approved Phase II trials to be conducted by the Canadian Center for Vaccinology (CCfV) on the COVID-19 vaccine produced by CanSino.

  8. FDA Gives Green Signal To Novavax's COVID-19-Influenza ... - AOL

    www.aol.com/fda-gives-green-signal-novavaxs...

    On Monday, the FDA removed the clinical hold on Novavax Inc.’s (NASDAQ:NVAX) Investigational New Drug (IND) application for its COVID-19-influenza combination (CIC) and stand-alone influenza ...

  9. Chloroquine and hydroxychloroquine during the COVID-19 ...

    en.wikipedia.org/wiki/Chloroquine_and_hydroxych...

    The authors came to the conclusion that no further trials of hydroxychloroquine or chloroquine for treatment of COVID-19 should be carried out. [58] On 26 April 2021, in its amended clinical management protocol for COVID-19, the Indian Ministry of Health lists hydroxychloroquine for use in patients during the early course of the disease. [23]